TY - JOUR
T1 - Waiting for the national cholesterol education program adult treatment panel IV guidelines, and in the meantime, some challenges and recommendations
AU - Martin, Seth S.
AU - Metkus, Thomas S.
AU - Horne, Aaron
AU - Blaha, Michael J.
AU - Hasan, Rani
AU - Campbell, Catherine Y.
AU - Yousuf, Omair
AU - Joshi, Parag
AU - Kaul, Sanjay
AU - Miller, Michael
AU - Michos, Erin D.
AU - Jones, Steven R.
AU - Gluckman, Ty J.
AU - Cannon, Christopher P.
AU - Sperling, Laurence S.
AU - Blumenthal, Roger S.
PY - 2012/7/15
Y1 - 2012/7/15
N2 - The National Cholesterol Education Program Adult Treatment Panel (ATP) has provided education and guidance for decades on the management of hypercholesterolemia. Its third report (ATP III) was published 10 years ago, with a white paper update in 2004. There is a need for translation of more recent evidence into a revised guideline. To help address the significant challenges facing the ATP IV writing group, this statement aims to provide balanced recommendations that build on ATP III. The authors aim for simplicity to increase the likelihood of implementation in clinical practice. To move from ATP III to ATP IV, the authors recommend the following: (1) assess risk more accurately, (2) simplify the starting algorithm, (3) prioritize statin therapy, (4) relax the follow-up interval for repeat lipid testing, (5) designate <70 mg/dl as an "ideal" low-density lipoprotein cholesterol target, (6) endorse targets beyond low-density lipoprotein cholesterol, (7) refine therapeutic target levels to the equivalent population percentile, (8) remove misleading descriptors such as "borderline high," and (9) make lifestyle messages simpler. In conclusion, the solutions offered in this statement represent ways to translate the totality of published reports into enhanced hyperlipidemia guidelines to better combat the devastating impact of hyperlipidemia on cardiovascular health.
AB - The National Cholesterol Education Program Adult Treatment Panel (ATP) has provided education and guidance for decades on the management of hypercholesterolemia. Its third report (ATP III) was published 10 years ago, with a white paper update in 2004. There is a need for translation of more recent evidence into a revised guideline. To help address the significant challenges facing the ATP IV writing group, this statement aims to provide balanced recommendations that build on ATP III. The authors aim for simplicity to increase the likelihood of implementation in clinical practice. To move from ATP III to ATP IV, the authors recommend the following: (1) assess risk more accurately, (2) simplify the starting algorithm, (3) prioritize statin therapy, (4) relax the follow-up interval for repeat lipid testing, (5) designate <70 mg/dl as an "ideal" low-density lipoprotein cholesterol target, (6) endorse targets beyond low-density lipoprotein cholesterol, (7) refine therapeutic target levels to the equivalent population percentile, (8) remove misleading descriptors such as "borderline high," and (9) make lifestyle messages simpler. In conclusion, the solutions offered in this statement represent ways to translate the totality of published reports into enhanced hyperlipidemia guidelines to better combat the devastating impact of hyperlipidemia on cardiovascular health.
UR - http://www.scopus.com/inward/record.url?scp=84862758583&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862758583&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2012.03.023
DO - 10.1016/j.amjcard.2012.03.023
M3 - Article
C2 - 22497674
AN - SCOPUS:84862758583
SN - 0002-9149
VL - 110
SP - 307
EP - 313
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 2
ER -